Effectiveness of cladribine tablets in the treatment of active relapsing-remitting multiple sclerosis: a multicenter, observational study

被引：0
|
作者：
Habek, M. [1 ]
Brecl, G. Jakob [2 ]
Rajda, C. [3 ]
Adamec, I. [4 ]
Barun, B. [4 ]
Rok, A. [2 ]
Ledinek, A. Horvat [2 ]
Rot, U. [2 ]
Jazbec, S. Sega [2 ]
Gabelic, T. [4 ]
Klivenyi, P. [3 ]
Skoric, M. Krbot [5 ]
机构：
[1] Univ Zagreb, Sch Med, Zagreb, Croatia
[2] Univ Med Ctr Ljubljana, Ljubljana, Slovenia
[3] Univ Szeged, Alber Szent Gyorgyi Hlth Ctr, Szeged, Hungary
[4] Univ Zagreb, Sch Med, Neurol, Zagreb, Croatia
[5] Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1135
引用
收藏
页码：894 / 894
页数：1
相关论文
共 50 条
  • [41] Oral cladribine in relapsing-remitting multiple sclerosis: study design of the 2-year, Phase IIIb CLARITY (CLAdRIbine tablets Treating multiple sclerosis orallY) extension study
    Giovannoni, G.
    Cook, S.
    Greenberg, S.
    Chang, P.
    Comi, G.
    Rieckmann, P.
    Sorensen, P. Soelberg
    Vermersch, P.
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 : 206 - 206
  • [42] Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study
    Sorensen, Per Soelberg
    Pontieri, Luigi
    Joensen, Hanna
    Heick, Alex
    Rasmussen, Peter Vestergaard
    Schafer, Jakob
    Ratzer, Rikke
    Pihl, Caroline Ellinore
    Sellebjerg, Finn
    Magyari, Melinda
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [43] COST-EFFECTIVENESS OF CLADRIBINE TABLETS IN THE TREATMENT OF PATIENTS WITH HIGHLY ACTIVE RELAPSING MULTIPLE SCLEROSIS IN PORTUGAL
    Pinheiro, B. A.
    Guerreiro, R.
    Costa, J.
    Silva Miguel, L.
    [J]. VALUE IN HEALTH, 2018, 21 : S339 - S339
  • [44] Efficacy and Safety Profile of Cladribine Tablets in an Italian Real-Life Cohort of Relapsing-Remitting Multiple Sclerosis Patients: A Monocentric Longitudinal Observational Study
    Zanetta, Chiara
    Rocca, Maria
    Meani, Alessandro
    Preziosa, Paolo
    Martinelli, Vittorio
    Ferre, Laura
    Moiola, Lucia
    Filippi, Massimo
    [J]. NEUROLOGY, 2023, 100 (17)
  • [45] Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing-remitting multiple sclerosis patients: a monocentric longitudinal observational study
    Zanetta, Chiara
    Rocca, Maria A.
    Meani, Alessandro
    Martinelli, Vittorio
    Ferre, Laura
    Moiola, Lucia
    Filippi, Massimo
    [J]. JOURNAL OF NEUROLOGY, 2023, 270 (07) : 3553 - 3564
  • [46] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [47] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    [J]. IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [48] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [49] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [50] Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort study
    Russo, P
    Paolillo, A
    Caprino, L
    Bastianello, S
    Bramanti, P
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2004, 10 (04) : 511 - 518
12345